Drug-Induced Photosensitivity: Medications That Cause Light Sensitivity

What Is Drug-Induced Photosensitivity?

Arm showing phototoxic drug reaction: sharp demarcation between sun-exposed forearm with intense erythema and blistering vs covered upper arm with normal skin

Drug-induced photosensitivity occurs when a medication — taken orally, applied topically, or administered by injection — makes your skin or eyes abnormally sensitive to ultraviolet (UV) radiation or visible light. This is one of the most common, most underrecognized, and most preventable causes of photosensitivity encountered in clinical medicine.

Estimates suggest that over 300 drugs have documented photosensitizing potential. The reactions range from mild sunburn-like redness that resolves quickly, to severe blistering skin reactions, ocular damage, long-term skin discoloration, and in rare cases (particularly with voriconazole), increased risk of skin cancer with prolonged use.

Because photosensitizing medications are extremely common — including everyday drugs like ibuprofen, hydrochlorothiazide, and doxycycline — drug-induced photosensitivity affects an enormous number of people. Many patients are never warned by their prescribing physician or pharmacist, and many reactions are misidentified as sunburns or allergic reactions.

This comprehensive guide covers every major drug class that causes photosensitivity, explains the two distinct reaction mechanisms, helps you recognize your reaction type, and provides evidence-based protection strategies.

All causes of light sensitivity → Sunscreen and UV protection →

Medical diagram showing drug molecule absorbing UV photon and transferring energy to DNA causing thymine dimer formation and reactive oxygen species

---

How Drug-Induced Photosensitivity Works: The Two Mechanisms

Understanding whether your reaction is phototoxic or photoallergic is essential — the mechanisms, clinical presentations, management, and long-term implications are fundamentally different.

Phototoxic Reactions

Mechanism: The drug (or its metabolite) absorbs UV radiation — primarily UVA (320–400 nm) — and enters an excited energy state. It then releases this energy in ways that damage nearby cells: generating reactive oxygen species, damaging DNA, and disrupting cell membranes.

Key characteristics:

• Most common type — accounts for the majority of drug photosensitivity reactions
• Occurs in virtually anyone taking a sufficient dose of the drug with sufficient UV exposure — not an immune response
• Dose-dependent: higher drug dose and higher UV exposure = more severe reaction
• Onset typically within hours of UV exposure
• Appearance: intense, exaggerated sunburn (erythema, edema, sometimes blistering) confined precisely to sun-exposed skin
• Resolves when medication is discontinued and skin heals
• Post-inflammatory hyperpigmentation (darkening of affected skin) may persist for months
• Can occur indoors near windows if UVA penetrates glass (UVA does penetrate standard window glass, unlike UVB)

Most photosensitizing drugs cause phototoxic reactions. Doxycycline, ciprofloxacin, amiodarone, hydrochlorothiazide, and voriconazole are the most clinically significant examples.

---

Photoallergic Reactions

Mechanism: UV radiation (primarily UVA) chemically alters the drug molecule, creating a new compound (photoallergen) that the immune system recognizes as foreign. This triggers a T-cell mediated delayed hypersensitivity response — the same mechanism as contact dermatitis.

Key characteristics:

• Less common than phototoxic reactions
• Immune-mediated — requires prior sensitization; first exposure produces sensitization (no reaction or mild reaction), subsequent exposures trigger the allergic response
• Can occur at doses too low to cause phototoxic reactions
• Onset typically 1–72 hours after UV exposure (delayed)
• Appearance: itchy, eczematous (eczema-like) rash that may spread beyond sun-exposed areas
• Can persist or worsen after the drug is discontinued — the immune sensitization remains
• May recur with re-exposure to chemically similar drugs (cross-reactivity)
• In rare cases, the photoallergen can sensitize to sunlight permanently (persistent light reactivity)

Common photoallergic drug culprits include: topical NSAIDs (especially ketoprofen), sunscreen chemical filters (oxybenzone, benzophenones), topical antihistamines (promethazine), and some sulfonamides.

---

Complete Guide to Photosensitizing Medications

Antibiotics

Antibiotics are the most commonly prescribed photosensitizing drug class. Many patients are prescribed these drugs without photosensitivity warnings, leading to avoidable reactions.

Tetracycline class (most photosensitizing antibiotic class):

• Doxycycline — the most commonly used tetracycline and one of the most clinically significant photosensitizing drugs. Used for acne, Lyme disease, chlamydia, malaria prophylaxis, rosacea, and many other conditions. Phototoxic reaction. Redness and burning can occur within hours of sun exposure at normal therapeutic doses. Many patients developing severe reactions while on doxycycline for acne.
• Tetracycline, minocycline, demeclocycline — all tetracyclines photosensitize, though doxycycline and demeclocycline have the highest reported rates.

Full guide: Doxycycline photosensitivity →

Fluoroquinolone class:

• Ciprofloxacin, levofloxacin, moxifloxacin, ofloxacin — moderate-to-significant phototoxicity risk. The fluoroquinolone ring absorbs UVA efficiently. Higher risk with longer treatment courses.

Sulfonamide class:

• Trimethoprim-sulfamethoxazole (Bactrim/Septra) — sulfonamide component is photosensitizing. Used for UTIs, MRSA skin infections, Pneumocystis prophylaxis.
• Sulfasalazine — used for IBD and rheumatoid arthritis; moderate photosensitivity risk.

---

Retinoids

Retinoids cause photosensitivity through a different mechanism from most photosensitizing drugs: they do not absorb UV directly, but they thin the stratum corneum (the skin’s outer protective barrier) and increase keratinocyte sensitivity to UV damage.

Oral retinoids:

• Isotretinoin (Accutane, Absorica, Claravis) — prescribed for severe acne; causes significant photosensitivity through stratum corneum thinning. Patients commonly report sunburning more easily than before treatment. Standard sunscreen (SPF 30+) plus protective clothing required throughout treatment.
• Acitretin — oral retinoid for psoriasis; similar photosensitivity mechanism.
• Bexarotene — oral retinoid for cutaneous T-cell lymphoma; photosensitivity significant.

Topical retinoids:

• Tretinoin (Retin-A) — most commonly used topical retinoid for acne and photoaging. Significant photosensitivity when applied to sun-exposed skin.
• Adapalene, tazarotene — similar photosensitizing potential.

Key management principle: Apply all topical retinoids at night only. Consistent daily sunscreen use is non-negotiable throughout retinoid treatment.

Full guide: Accutane photosensitivity →

---

Cardiovascular and Diuretic Medications

Amiodarone — one of the most severe photosensitizing drugs in clinical medicine. This antiarrhythmic accumulates in the skin and other tissues, and its iodine-containing ring system efficiently absorbs UV radiation. Causes:

• Erythematous phototoxic reactions in sun-exposed areas
• With prolonged use (months to years): permanent blue-gray skin discoloration (pseudo-cyanosis) in sun-exposed areas that may be irreversible even after stopping the drug
• Ocular deposits (corneal microdeposits nearly universal; more serious lens and optic nerve effects in some patients) Patients on amiodarone require aggressive, year-round UV protection indefinitely.

Hydrochlorothiazide (HCTZ) — one of the most widely prescribed medications in the world (used for hypertension and heart failure), and increasingly recognized as causing photosensitivity and potentially increasing non-melanoma skin cancer risk with long-term use. Studies have found associations between chronic HCTZ use and lip cancer and other sun-related skin cancers.

Furosemide (Lasix) — loop diuretic with moderate photosensitivity risk, less than HCTZ.

ACE inhibitors — some evidence for photosensitivity, particularly captopril.

Nifedipine and diltiazem — calcium channel blockers with reported photosensitivity, generally mild.

---

Antifungal Medications

Voriconazole — the most severe photosensitizer in this class, with unique and serious implications. Causes phototoxic reactions at standard doses and with cumulative UV exposure. Long-term voriconazole use (common in immunocompromised patients with invasive fungal infections) has been associated with significantly increased risk of squamous cell carcinoma and other skin cancers in sun-exposed areas. Rigorous, year-round UV protection is mandatory for all patients on chronic voriconazole therapy.

Griseofulvin — oral antifungal for dermatophyte infections; moderate photosensitivity risk.

---

Psychiatric and Neurological Medications

Antipsychotics:

• Chlorpromazine — first-generation antipsychotic; high photosensitivity risk; also causes permanent blue-gray pigmentation with long-term sun exposure.
• Quetiapine, olanzapine — newer antipsychotics; lower but still present photosensitivity risk.
• Thioridazine, prochlorperazine — phenothiazine class; moderate photosensitivity.

Mood stabilizers and anticonvulsants:

• Carbamazepine (Tegretol) — moderate photosensitivity.
• Lamotrigine — moderate photosensitivity.
• Valproate — lower risk.

Antidepressants:

• Tricyclic antidepressants (amitriptyline, imipramine, desipramine) — moderate photosensitivity; also affect pupillary constriction, potentially worsening ocular photophobia.
• SSRIs (sertraline, fluoxetine, paroxetine) — mild photosensitivity; often underrecognized.
• St. John’s Wort (hypericum) — dietary supplement with significant phototoxic potential; often overlooked because it is “natural.”

---

NSAIDs (Non-Steroidal Anti-Inflammatory Drugs)

Piroxicam — highest photosensitizing risk of the common NSAIDs; responsible for both phototoxic and photoallergic reactions. Can cause particularly severe blistering reactions.

Ketoprofen — topical formulation especially problematic; photoallergic reactions reported weeks after discontinuation; cross-reactivity with related compounds (benzophenones in some sunscreens).

Naproxen (Aleve, Naprosyn) — moderate photosensitivity risk; most commonly phototoxic.

Ibuprofen — low photosensitivity risk; documented but uncommon.

Celecoxib — sulfonamide component; some photosensitivity potential.

---

Cancer Chemotherapy

Several chemotherapy agents cause significant photosensitivity, sometimes requiring treatment modification or aggressive UV protection:

• 5-fluorouracil (5-FU) — significant photosensitivity; recall reactions in previously irradiated skin (radiation recall phenomenon).
• Methotrexate — photosensitivity and radiation recall.
• Dacarbazine (DTIC) — high photosensitivity.
• Vemurafenib — BRAF inhibitor; severe photosensitivity in many patients.
• Vandetanib — kinase inhibitor; photosensitivity.
• Taxanes (paclitaxel, docetaxel) — radiation recall and photosensitivity.

---

Other Medications with Photosensitivity Risk

Drug	Class	Reaction Type	Severity
Methotrexate	Immunosuppressant	Phototoxic	Moderate
Hydroxychloroquine	Antimalarial/lupus	Photoprotective (paradoxically)	—
Quinine	Antimalarial	Photoallergic	Moderate
Oral contraceptives	Hormonal	Phototoxic (melasma)	Mild-moderate
Glyburide, glipizide	Sulfonylurea antidiabetics	Phototoxic	Mild
Isotretinoin	Retinoid	Indirect (barrier)	Moderate
Coal tar	Topical dermatology	Phototoxic	Significant
Benzoyl peroxide	Topical acne	Mild	Low

---

Recognizing Drug-Induced Photosensitivity: Diagnostic Clues

A drug photosensitivity reaction should be suspected when:

1. New skin reaction that appears exclusively or predominantly in sun-exposed areas (face, neck, dorsal hands, forearms, “V” of the chest, scalp in bald individuals)
2. Temporal relationship to a recently started medication or increased dose
3. Appearance after relatively brief sun exposure that would not normally cause sunburn
4. Skin-spared areas match covered skin — under clothing, watch bands, and hair are characteristically spared in phototoxic reactions

Phototoxic vs. photoallergic: telling them apart clinically

Feature	Phototoxic	Photoallergic
Timing after exposure	Hours	1–3 days
Appearance	Exaggerated sunburn	Eczema-like rash
Distribution	Only sun-exposed areas	May spread beyond
Immune mechanism	No	Yes
Persists after stopping	No	Can persist
Prior sensitization needed	No	Yes
Dose relationship	Yes	Less pronounced

---

High-Risk Patient Populations

Certain patients have significantly elevated risk of severe drug photosensitivity reactions:

• Patients with lupus (SLE) — already have photosensitivity; adding photosensitizing drugs can trigger severe flares
• Organ transplant recipients — immunosuppressed and often on multiple photosensitizing drugs (voriconazole, others); dramatically increased skin cancer risk
• HIV-positive patients on trimethoprim-sulfamethoxazole prophylaxis — prolonged high-dose TMP-SMX with significant UV exposure
• Patients on chronic amiodarone — cumulative years of photosensitizer accumulation; irreversible pigmentation and potential optic neuropathy
• Elderly patients — often on multiple photosensitizing drugs (diuretics, cardiac medications) with thinner, less protective skin
• Fair-skinned individuals — less melanin protection amplifies any photosensitizing effect

---

Ocular Drug Photosensitivity

While most drug photosensitivity discussions focus on skin, several medications cause ocular light sensitivity as well:

Chloroquine and hydroxychloroquine: Can cause corneal deposits (corneal verticillata) that cause halo vision and light sensitivity. Long-term use requires ophthalmology monitoring.

Amiodarone: Corneal microdeposits occur in nearly all patients on long-term therapy; usually subclinical but can cause halo vision. Optic neuropathy (rare but serious) can cause significant ocular photophobia.

Isotretinoin: Reports of decreased night vision, dry eyes (reduced meibomian gland function), and associated photophobia during treatment.

Tricyclic antidepressants: Anticholinergic effects dilate the pupil, increasing light reaching the retina and worsening pre-existing ocular photophobia.

Vigabatrin (anticonvulsant): Can cause irreversible visual field loss and associated photophobia.

---

Protection Strategies When on Photosensitizing Medications

Sunscreen

Broad-spectrum SPF 50+ sunscreen is the minimum standard when taking photosensitizing medications. Key points:

• Broad-spectrum is non-negotiable — most drug photosensitivity reactions are primarily UVA-mediated, and many sunscreens with high SPF ratings protect inadequately against UVA. Look for “broad-spectrum” on the label.
• SPF 50 or higher — provides approximately 98% UVB filtration; higher SPF provides margin of error for imperfect application.
• Apply 30 minutes before sun exposure and reapply every 2 hours, or after swimming/sweating.
• Year-round application to exposed areas — UVA penetrates clouds and glass in all seasons.
• Physical (mineral) sunscreens (zinc oxide, titanium dioxide) are preferred for photosensitive skin — they block UV physically and are less irritating than chemical UV filters.

Full sunscreen guide →

---

Protective Clothing and Behavior

• UPF-rated clothing — UPF 50+ fabric blocks 98% of UV. Long sleeves, long pants, and collared shirts dramatically reduce UV exposure to the trunk and extremities.
• Wide-brimmed hat (3-inch brim minimum) — protects the face, neck, scalp, and ears.
• UV-blocking sunglasses (UV400) — protect the eyes and periorbital skin; particularly important for drugs causing ocular photosensitivity.
• Avoid peak UV hours (10 AM – 4 PM) when possible.
• Seek shade — even in shade, reflected UV from surfaces provides some exposure.
• Window film — for patients on high-risk medications like amiodarone or voriconazole, UV-blocking window film applied to car and home windows provides important protection from indoor UVA exposure.

---

Medication Management

Never stop a medication independently because of photosensitivity concerns. The risks of stopping many photosensitizing medications (amiodarone, antipsychotics, chemotherapy) far outweigh photosensitivity risks. Always discuss with your prescribing physician.

What to discuss with your doctor:

• Is there an alternative medication with lower photosensitivity potential for your condition?
• Can the dose be reduced while maintaining therapeutic effect?
• What are the expected duration and severity of photosensitivity?
• What sun protection level is needed?
• Are there any signs of reaction that warrant contacting the office promptly?

---

When to Seek Medical Attention

Seek urgent care if you develop:

• Blistering or severe skin breakdown in sun-exposed areas
• Swelling, particularly facial swelling, alongside skin rash
• Any sign of systemic reaction (fever, widespread rash, mucosal involvement)
• Ocular symptoms (pain, vision changes, redness) alongside photosensitivity

Contact your doctor within a few days if you develop:

• New or worsening skin rash in sun-exposed areas after starting a medication
• Skin reactions that are unusually severe for the amount of sun you received
• Any skin reaction that persists or spreads after limiting sun exposure
• Signs of ocular light sensitivity alongside a new medication

---

Frequently Asked Questions

If I stop the medication, will my photosensitivity go away? For phototoxic reactions: yes, photosensitivity resolves as the drug clears from your system (days to weeks for most drugs; longer for drugs that accumulate like amiodarone). Skin darkening may persist for months. For photoallergic reactions: the immune sensitization can persist, though reactions typically diminish over time with UV avoidance.

Can indoor light cause drug photosensitivity reactions? Yes — UVA penetrates standard window glass. Patients near sunny windows or in vehicles can receive meaningful UVA doses indoors. The highest-risk drugs (amiodarone, voriconazole) require UV protection even with indoor sun exposure.

Do I need to avoid the sun forever if I’m on one of these drugs? Not necessarily. Many photosensitizing medications are used for limited courses (doxycycline for 7–14 days for an infection). For long-term medications, consistent sun protection — rather than complete sun avoidance — is the practical goal.

My doctor didn’t mention photosensitivity. Is it really a problem? Many clinicians don’t routinely counsel patients on photosensitivity risks. Check your medication package insert or ask your pharmacist. Doxycycline, HCTZ, and ciprofloxacin package inserts all contain photosensitivity warnings.

---

Sources

1. Blakely KM, Drucker AM, Rosen CF. “Drug-induced photosensitivity—an update.” Drug Safety. 2019;42(7):827-847.
2. Gould JW, Mercurio MG, Elmets CA. “Cutaneous photosensitivity diseases induced by exogenous agents.” Journal of the American Academy of Dermatology. 1995;33(4):551-573.
3. Moore DE. “Drug-induced cutaneous photosensitivity: incidence, mechanism, prevention and management.” Drug Safety. 2002;25(5):345-372.
4. Viola G, et al. “Phototoxicity and photomutagenicity of fluoroquinolones.” Free Radical Biology and Medicine. 2008.
5. Friis-Hansen L, et al. “Hydrochlorothiazide use and risk of skin cancers.” Journal of Internal Medicine. 2020.
6. Epstein JH. “Phototoxicity and photoallergy.” Seminars in Cutaneous Medicine and Surgery. 1999;18(4):274-284.
7. Ferguson J. “Photosensitivity due to drugs.” Photodermatology, Photoimmunology & Photomedicine. 2002;18(5):262-269.